Lentiviral Gene Delivery Tools: A Comprehensive Webinar Guide

Added:

Non-Integrating and Non-Viral Gene Delivery Alternatives

While lentiviral vectors are highly efficient for stable genetic modification, they present significant safety and manufacturing challenges. The primary concern is insertional mutagenesis, where the semi-random integration of the viral genome into the host cell's DNA can disrupt tumor suppressor genes or activate oncogenes, potentially leading to oncogenesis. Additionally, lentiviral production is complex, expensive, and carries a theoretical risk of generating replication-competent retroviruses. An active counter-perspective in gene therapy advocates for non-integrating viral systems, such as Adeno-Associated Viruses (AAVs), or non-viral delivery methods, including lipid nanoparticles (LNPs) and electroporation of CRISPR-Cas9 ribonucleoproteins. These alternative technologies offer transient gene expression or highly precise genome editing without integrating foreign DNA into the host genome, thereby minimizing the risk of genotoxicity and providing a safer, more scalable path for therapeutic applications.

Fundamentals of virology, specifically the biology, genomic structure, and replication cycle of retroviruses.
Basic principles of recombinant DNA technology, including plasmid vector design, promoters, and transfection.
The distinction between transient gene expression and stable genomic integration within host cells.
Standard mammalian cell culture techniques, as these are critical for both virus production and transduction.
Clinical applications of lentiviral vectors, such as CAR-T cell immunotherapy and ex vivo gene therapy for monogenic disorders.
Advanced methodologies for lentiviral titration, purification, and quality control metrics (e.g., determining physical vs. functional titers).
Biosafety standards (BSL-2/BSL-2+) and regulatory guidelines (cGMP) governing the manufacture and clinical use of viral vectors.
Comparative study of alternative gene delivery systems, including Adeno-Associated Virus (AAV) vectors and non-viral lipid nanoparticles (LNPs).
5.8K views100likes35:44@origenesocialOriginal Release: 2022-12-08

Lentivirus is a powerful gene delivery tool derived from HIV-1 that enables efficient transduction of both dividing and non-dividing cells with high efficiency (90-100%), permanent genome integration for long-term expression, and carrying capacity up to 9 kb; third-generation lentiviral systems enhance safety by splitting packaging genes across multiple plasmids, removing the tat gene, and incorporating self-inactivation mutations, making them suitable for BSL-2 laboratory environments.